PT-141 Pen research peptideBest Seller
Sexual Health

PT-141 Pen

Pre-loaded PT-141 (Bremelanotide) research pen. Investigated for its activity at central melanocortin receptors.

Purity

99%+

CAS Number

189691-06-3

Status

In Stock

Dispatch

Same-Day (before 2pm)

Select Size

£149.99

Research verification required. All orders are reviewed before dispatch. You will receive an email confirmation and a WhatsApp or phone call within 60 minutes to verify your research purpose.

Third-Party CoA Included Free Delivery Over £75 Research Use Only

About PT-141 Pen

PT-141, also known as Bremelanotide, is a synthetic cyclic-peptide melanocortin-receptor agonist studied for its activity at MC3-R and MC4-R in central nervous system research models. Unlike vasoactive compounds that act on peripheral blood flow, PT-141 has been investigated for centrally mediated pathways relevant to arousal and behavioural research. Supplied as a pre-loaded research pen for in-vitro and preclinical applications.

Research Applications

Research Mechanism — PT-141 Pen

A simplified summary of what PT-141 Pen is studied for in research models. For laboratory in-vitro use only.

Sequence:Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH

Origin: Synthetic cyclic heptapeptide analogue of α-MSH, derived from the Melanotan II scaffold and produced by solid-phase peptide synthesis.

  1. Molecular target

    A cyclic melanocortin-receptor agonist investigated for its binding affinity to central nervous system melanocortin receptors in research models.

    • Melanocortin-4 receptor (MC4-R)
    • Melanocortin-3 receptor (MC3-R)
    • Hypothalamic paraventricular nucleus circuits
  2. Investigated pathways

    Preclinical studies have explored downstream effects on Gαs-coupled cAMP signalling, central neurotransmitter release, and autonomic-response markers in animal research.

    • Gαs-coupled cAMP–PKA signalling
    • Hypothalamic dopamine release studies
    • Oxytocinergic neurocircuit response assays
  3. Preclinical research applications

    Used as a research tool in laboratory models exploring melanocortin neurobiology, central-nervous-system pharmacology, and behavioural-response research. Not approved for human use.

    • Rodent melanocortin receptor binding assays
    • Central nervous system signalling models
    • Behavioural neuroscience research studies

For research use only. PT-141 Pen is not approved as a medicine in the UK and is not intended for human or veterinary administration. See the compliance page for full terms.

Technical Specifications

Compound NamePT-141 Pen
CategorySexual Health
CAS Number189691-06-3
Molecular Weight1025.18 g/mol
Molecular FormulaC₅₀H₆₈N₁₄O₁₀
SequenceAc-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Purity≥99%+ (HPLC)
FormLyophilised powder
StorageStore at 2–8°C. Protect from light. Use within 30 days of opening.
ReconstitutionPre-formulated in solution; no reconstitution required.

Certificate of Analysis

Every order of PT-141 Pen includes a batch-specific CoA with HPLC chromatogram, mass spectrometry data, and laboratory accreditation details.

View Sample CoA

PT-141 Pen — Frequently Asked Questions

What is PT-141?

PT-141 (Bremelanotide) is a synthetic cyclic peptide investigated as a melanocortin-receptor agonist in central nervous system research.

What purity is your PT-141 pen?

99%+, confirmed by independent third-party HPLC analysis. Batch-specific CoA included.

Is PT-141 approved for human use?

No. Supplied for in-vitro laboratory research only. PT-141 is still experimental and not recommended for human consumption.

PT-141 Pen is supplied by Premio Peptides (BELL RED LIMITED) exclusively for in vitro laboratory research. It is not a licensed medicine, is not approved for human or veterinary use, and must not be administered to any living organism outside a formally approved research protocol. Purchasers assume full responsibility for compliance with applicable regulations.

Related Compounds